Peripheral hypertrophic subepithelial degeneration – case report Case report

Main Article Content

Dorota Wyględowska-Promieńska
Łukasz Drzyzga
Dorota Śpiewak
Mariola Dorecka

Abstract

Purpose: The aim of the paper is to present the case of a 53-year-old female patient who, based on the clinical picture and optical coherent tomography of the anterior segment (AS-OCT), was diagnosed with peripheral hypertrophic subepithelial degeneration (PHSD) and underwent surgical treatment in the form of superficial keratectomy with mechanical removal of degenerative plaques.


Methods: Analysis of AS-OCT images and corneal tomography based on Scheimpflug images and surgical treatment – superficial keratectomy with mechanical removal of degenerative plaques.


Results: Before treatment, the best corrected visual acuity (BCVA) for distance, as assessed by the Snellen chart, was 3/50 c.cor +10.50/-6.50 ax 18° in the right eye (RE) and in the left eye (LE) 5/10 c.cor +10.75/-3.00 ax 48°. Preoperative keratometry performed with the Pentacam device was K1 32.7 D and K2 46.0 D in the OP and K1 42.5 D and K2 44.7 D in the LE. Postoperative BCVA in RE was 5/8 c.cor +3.50/-1.00 ax 120° at 5 months of follow-up and in LE 5/6 c.cor +4.75/-1.00 ax 64° at 3rd month of observation. Postoperative keratometry (Pentacam) in RE K1 was 44.6 D, K2 46.9 D in the 5th month of observation, and in LE K1 45.6 D, K2 46.5 D in the 3rd month of observation. As a result of the treatment, BCVA improved, astigmatism decreased and corneal translucency improved.


Conclusions: AS-OCT and Scheimpflug-based corneal tomography are helpful in the diagnosis of PHSD. Superficial keratectomy with mechanical removal of degenerative plaques seems to be an effective treatment for PHSD

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Wyględowska-Promieńska D, Drzyzga Łukasz, Śpiewak D, Dorecka M. Peripheral hypertrophic subepithelial degeneration – case report. Ophthatherapy [Internet]. 2023Dec.31 [cited 2024Feb.26];10(4):262-7. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/2940
Section
Conservative treatment

References

1. Gunzinger JM, Voulgari N, Petrovic A et al. Peripheral hypertrophic subepithelial corneal degeneration: clinical aspects related to in vivo confocal microscopy and optical coherence tomography. Int Med Case Rep J. 2019; 12: 237-41.
2. Järventausta PJ, Tervo TM, Kivela T et al. Peripheral hypertrophic subepithelial corneal degeneration – clinical and histopathological features. Acta Ophthalmol. 2014; 92(8): 774-82.
3. Raber IM, Eagle RC, Jr. Peripheral Hypertrophic Subepithelial Corneal Degeneration. Cornea. 2022; 41(2): 183-91.
4. Maust HA, Raber IM. Peripheral hypertrophic subepithelial corneal degeneration. Eye Contact Lens. 2003; 29(4): 266-9.
5. Jeng BH, Millstein ME. Reduction of hyperopia and astigmatism after superficial keratectomy of peripheral hypertrophic subepithelial corneal degeneration. Eye Contact Lens. 2006; 32: 153-6.
6. Gore DM, Iovieno A, Connell BJ et al. Peripheral hypertrophic subepithelial corneal degeneration: nomenclature, phenotypes, and long-term outcomes. Ophthalmology. 2013; 120: 892-8.
7. Farjo AA, Halperin GI, Syed N et al. Salzmann’s nodular corneal degeneration clinical characteristics and surgical outcomes. Cornea. 2006; 25: 11-5.
8. Ding Y, Murri MS, Birdsong OC et al. Terrien marginal degeneration. Surv Ophthalmol. 2019; 64(2): 162-74.
9. Mandal S, Sachdeva G, Nagpal R et al. Early onset unilateral Terrien’s marginal degeneration. BMJ Case Rep. 2022; 15(7): e248889.